10-K Filing

Astrana Health, Inc. CIK: 1083446 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0001628280-24-008024`
Period End Date	20231231
Filing Date	20240229
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	asth-20231231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 107 Income Statement 60 Cash Flow Statement 210 Stockholders Equity 53

Balance Sheet 107 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$288.03M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$233.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$293.81M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$5.57M	USD	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$2.50M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`SharesOutstanding`	46.58M	shares	Point-in-time
Income taxes receivable	`IncomeTaxesReceivable`	-	USD	Point-in-time
Common stock, shares outstanding (in shares)	`SharesOutstanding`	46.84M	shares	Point-in-time
Income taxes receivable	`IncomeTaxesReceivable`	$10.66M	USD	Point-in-time
Treasury stock, common, shares (in shares)	`TreasuryStockCommonShares`	10.58M	shares	Point-in-time
Treasury stock, common, shares (in shares)	`TreasuryStockCommonShares`	10.30M	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$1.83M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$1.33M	USD	Point-in-time
Assets	`Assets`	$966.21M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$17.45M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$14.80M	USD	Point-in-time
Assets	`Assets`	$933.36M	USD	Point-in-time
Liabilities	`Liabilities`	$522.59M	USD	Point-in-time
Liabilities	`Liabilities`	$407.67M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$461.51M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$428.12M	USD	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$7.17M	USD	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$108.54M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$71.65M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$76.86M	USD	Point-in-time
Goodwill	`Goodwill`	$278.83M	USD	Point-in-time
Goodwill	`Goodwill`	$269.05M	USD	Point-in-time
Goodwill	`Goodwill`	$246.42M	USD	Point-in-time
Income taxes receivable	`IncomeTaxesReceivableNoncurrent`	$15.94M	USD	Point-in-time
Income taxes receivable	`IncomeTaxesReceivableNoncurrent`	$15.94M	USD	Point-in-time
Loans receivable, non-current	`NotesAndLoansReceivableNetNoncurrent`	-	USD	Point-in-time
Loans receivable, non-current	`NotesAndLoansReceivableNetNoncurrent`	$26.47M	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$25.77M	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$40.30M	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$41.72M	USD	Point-in-time
Investments in privately held entities	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$6.40M	USD	Point-in-time
Investments in privately held entities	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$2.40M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$345.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	-	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$20.44M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$37.40M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.56M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.88M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$538.09M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$471.85M	USD	Point-in-time
Total assets	`Assets`	$966.21M	USD	Point-in-time
Total assets	`Assets`	$933.36M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$59.95M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$49.56M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$7.74M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$8.06M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$55.78M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$81.25M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$106.66M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$4.28M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	-	USD	Point-in-time
Dividend payable	`DividendsPayableCurrent`	$638.00K	USD	Point-in-time
Dividend payable	`DividendsPayableCurrent`	$664.00K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$646.00K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$594.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$4.61M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$3.57M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$19.50M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$619.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesCurrent`	-	USD	Point-in-time
Other liabilities	`OtherLiabilitiesCurrent`	$18.94M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$218.67M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$148.61M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$14.22M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$4.07M	USD	Point-in-time
Finance lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$1.27M	USD	Point-in-time
Finance lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$1.03M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$36.29M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$19.91M	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	$258.94M	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	$203.39M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$20.26M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$3.59M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$259.06M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$303.92M	USD	Point-in-time
Total liabilities	`Liabilities`	$522.59M	USD	Point-in-time
Total liabilities	`Liabilities`	$407.67M	USD	Point-in-time
Commitments and contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation (APC)	`TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$-205.88M	USD	Point-in-time
Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation (APC)	`TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$14.24M	USD	Point-in-time
Common stock, par value $0.001; 100,000,000 shares authorized, 46,843,743 and 46,575,699 shares outstanding, excluding 10,584,340 and 10,299,259 treasury shares, at December 31, 2023 and 2022, respectively	`CommonStockValue`	$47.00K	USD	Point-in-time
Common stock, par value $0.001; 100,000,000 shares authorized, 46,843,743 and 46,575,699 shares outstanding, excluding 10,584,340 and 10,299,259 treasury shares, at December 31, 2023 and 2022, respectively	`CommonStockValue`	$47.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$371.04M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$360.10M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$243.13M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$182.42M	USD	Point-in-time
Stockholders' equity attributable to parent	`StockholdersEquity`	$614.22M	USD	Point-in-time
Stockholders' equity attributable to parent	`StockholdersEquity`	$542.56M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$1.75M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$2.43M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$544.31M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$616.65M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$454.11M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$329.46M	USD	Point-in-time
Total liabilities, mezzanine equity (deficit), and stockholders equity	`LiabilitiesAndStockholdersEquity`	$966.21M	USD	Point-in-time
Total liabilities, mezzanine equity (deficit), and stockholders equity	`LiabilitiesAndStockholdersEquity`	$933.36M	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.14B	USD	Annual
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.39B	USD	Annual
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$773.91M	USD	Annual
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$944.68M	USD	Annual
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$1.17B	USD	Annual
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$596.14M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$77.67M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$112.60M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$62.08M	USD	Annual
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$17.54M	USD	Annual
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$17.52M	USD	Annual
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$17.75M	USD	Annual
Total expenses	`CostsAndExpenses`	$1.04B	USD	Annual
Total expenses	`CostsAndExpenses`	$1.30B	USD	Annual
Total expenses	`CostsAndExpenses`	$675.74M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$84.61M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$98.18M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$104.27M	USD	Annual
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-4.31M	USD	Annual
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$5.58M	USD	Annual
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$5.62M	USD	Annual
Gain on sale of equity method investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$2.19M	USD	Annual
Gain on sale of equity method investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	Annual
Gain on sale of equity method investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	Annual
Interest expense	`InterestExpense`	$7.92M	USD	Annual
Interest expense	`InterestExpense`	$5.39M	USD	Annual
Interest expense	`InterestExpense`	$16.10M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$14.21M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$1.57M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$1.98M	USD	Annual
Unrealized loss on investments	`UnrealizedGainLossOnInvestments`	$-4.58M	USD	Annual
Unrealized loss on investments	`UnrealizedGainLossOnInvestments`	$-10.74M	USD	Annual
Unrealized loss on investments	`UnrealizedGainLossOnInvestments`	$-21.27M	USD	Annual
Other income (loss)	`OtherNonoperatingIncomeExpense`	$3.94M	USD	Annual
Other income (loss)	`OtherNonoperatingIncomeExpense`	$6.12M	USD	Annual
Other income (loss)	`OtherNonoperatingIncomeExpense`	$-3.75M	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$-20.43M	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$-17.65M	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$5.22M	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$77.75M	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$89.84M	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$86.62M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$31.99M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$40.88M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$31.69M	USD	Annual
Net income	`ProfitLoss`	$57.85M	USD	Annual
Net income	`ProfitLoss`	$45.74M	USD	Annual
Net income	`ProfitLoss`	$46.05M	USD	Annual
Net (loss) income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-22.87M	USD	Annual
Net (loss) income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$570.00K	USD	Annual
Net (loss) income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.87M	USD	Annual
Net income attributable to Astrana Health, Inc.	`NetIncomeLoss`	$60.72M	USD	Annual
Net income attributable to Astrana Health, Inc.	`NetIncomeLoss`	$45.17M	USD	Annual
Net income attributable to Astrana Health, Inc.	`NetIncomeLoss`	$68.92M	USD	Annual
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$1.57	USD	Annual
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$1.30	USD	Annual
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$1.00	USD	Annual
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.99	USD	Annual
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.52	USD	Annual
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.29	USD	Annual

Cash Flow Statement 210 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$57.85M	USD	Annual
Net income	`ProfitLoss`	$45.74M	USD	Annual
Net income	`ProfitLoss`	$46.05M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$17.52M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$17.54M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$17.75M	USD	Annual
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	$1.08M	USD	Annual
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	$1.06M	USD	Annual
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	$939.00K	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$16.10M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$6.75M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$22.04M	USD	Annual
Non-cash lease expense	`NoncashLeaseExpense`	$3.76M	USD	Annual
Non-cash lease expense	`NoncashLeaseExpense`	$7.18M	USD	Annual
Non-cash lease expense	`NoncashLeaseExpense`	$3.13M	USD	Annual
(Income) loss from equity method investments, net	`IncomeLossFromEquityMethodInvestments`	$-4.31M	USD	Annual
(Income) loss from equity method investments, net	`IncomeLossFromEquityMethodInvestments`	$5.58M	USD	Annual
(Income) loss from equity method investments, net	`IncomeLossFromEquityMethodInvestments`	$5.62M	USD	Annual
Unrealized loss on investments	`UnrealizedGainLossFromInvestmentInEquitySecurities`	$-25.51M	USD	Annual
Unrealized loss on investments	`UnrealizedGainLossFromInvestmentInEquitySecurities`	$-4.78M	USD	Annual
Unrealized loss on investments	`UnrealizedGainLossFromInvestmentInEquitySecurities`	$-10.85M	USD	Annual
Unrealized (gain) loss on interest rate swaps	`UnrealizedGainLossOnDerivatives`	$4.24M	USD	Annual
Unrealized (gain) loss on interest rate swaps	`UnrealizedGainLossOnDerivatives`	$-1.07M	USD	Annual
Unrealized (gain) loss on interest rate swaps	`UnrealizedGainLossOnDerivatives`	$201.00K	USD	Annual
Gain on sale or distribution of investments	`GainOnSaleOfInvestments`	$2.27M	USD	Annual
Gain on sale or distribution of investments	`GainOnSaleOfInvestments`	$1.25M	USD	Annual
Gain on sale or distribution of investments	`GainOnSaleOfInvestments`	$2.19M	USD	Annual
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$7.67M	USD	Annual
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$-12.44M	USD	Annual
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$-14.28M	USD	Annual
Loss (gain) on consolidation of equity method investment	`GainLossOnConsolidationOfEquityMethodInvestment`	-	USD	Annual
Loss (gain) on consolidation of equity method investment	`GainLossOnConsolidationOfEquityMethodInvestment`	$2.75M	USD	Annual
Loss (gain) on consolidation of equity method investment	`GainLossOnConsolidationOfEquityMethodInvestment`	$-901.00K	USD	Annual
Gain on contingent equity securities	`GainLossOnEquityReceivable`	$4.27M	USD	Annual
Gain on contingent equity securities	`GainLossOnEquityReceivable`	-	USD	Annual
Gain on contingent equity securities	`GainLossOnEquityReceivable`	-	USD	Annual
Gain from investment in warrants	`FairValueAdjustmentOfWarrants`	$-1.15M	USD	Annual
Gain from investment in warrants	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Gain from investment in warrants	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Impairment of beneficial interest	`OtherAssetImpairmentCharges`	-	USD	Annual
Impairment of beneficial interest	`OtherAssetImpairmentCharges`	$15.72M	USD	Annual
Impairment of beneficial interest	`OtherAssetImpairmentCharges`	-	USD	Annual
Other	`ProceedsFromOtherOperatingActivities`	$422.00K	USD	Annual
Other	`ProceedsFromOtherOperatingActivities`	$189.00K	USD	Annual
Other	`ProceedsFromOtherOperatingActivities`	-	USD	Annual
Receivable, net	`IncreaseDecreaseInAccountsReceivable`	$38.19M	USD	Annual
Receivable, net	`IncreaseDecreaseInAccountsReceivable`	$1.52M	USD	Annual
Receivable, net	`IncreaseDecreaseInAccountsReceivable`	$26.73M	USD	Annual
Receivable, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$-4.23M	USD	Annual
Receivable, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$20.12M	USD	Annual
Receivable, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$-6.17M	USD	Annual
Other receivable	`IncreaseDecreaseInOtherReceivables`	$-8.20M	USD	Annual
Other receivable	`IncreaseDecreaseInOtherReceivables`	$5.35M	USD	Annual
Other receivable	`IncreaseDecreaseInOtherReceivables`	$-311.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$2.96M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$-2.71M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$-818.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-2.86M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.53M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$243.00K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$3.22M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-49.00K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-170.00K	USD	Annual
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$-2.47M	USD	Annual
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$892.00K	USD	Annual
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$-328.00K	USD	Annual
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$18.61M	USD	Annual
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$5.28M	USD	Annual
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$22.79M	USD	Annual
Income taxes payable/receivable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-14.01M	USD	Annual
Income taxes payable/receivable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-14.48M	USD	Annual
Income taxes payable/receivable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$6.92M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-6.67M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-3.21M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-3.94M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$68.23M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$82.13M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$70.33M	USD	Annual
Payments for business and asset acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$6.51M	USD	Annual
Payments for business and asset acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$16.35M	USD	Annual
Payments for business and asset acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$2.58M	USD	Annual
Proceeds from repayment of loans receivable - related parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	$2.68M	USD	Annual
Proceeds from repayment of loans receivable - related parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	$4.07M	USD	Annual
Proceeds from repayment of loans receivable - related parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	$56.00K	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$28.00M	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$1.85M	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$2.15M	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$491.00K	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$67.61M	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$31.67M	USD	Annual
Issuance of loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	Annual
Issuance of loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	Annual
Issuance of loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	$26.47M	USD	Annual
Purchases of investments privately held	`PaymentsToAcquireTradingSecuritiesHeldforinvestment`	-	USD	Annual
Purchases of investments privately held	`PaymentsToAcquireTradingSecuritiesHeldforinvestment`	$4.00M	USD	Annual
Purchases of investments privately held	`PaymentsToAcquireTradingSecuritiesHeldforinvestment`	-	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$22.94M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$19.22M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$28.53M	USD	Annual
Purchases of investments equity method	`PaymentsToAcquireEquityMethodInvestments`	$13.62M	USD	Annual
Purchases of investments equity method	`PaymentsToAcquireEquityMethodInvestments`	$325.00K	USD	Annual
Purchases of investments equity method	`PaymentsToAcquireEquityMethodInvestments`	-	USD	Annual
Proceeds from sale of equity method investment	`ProceedsFromSaleOfEquityMethodInvestments`	-	USD	Annual
Proceeds from sale of equity method investment	`ProceedsFromSaleOfEquityMethodInvestments`	-	USD	Annual
Proceeds from sale of equity method investment	`ProceedsFromSaleOfEquityMethodInvestments`	$6.38M	USD	Annual
Distribution from investment - equity method	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$400.00K	USD	Annual
Distribution from investment - equity method	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	-	USD	Annual
Distribution from investment - equity method	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	-	USD	Annual
Contribution to investment - equity method	`PaymentsToEquityMethodInvestments`	-	USD	Annual
Contribution to investment - equity method	`PaymentsToEquityMethodInvestments`	$2.10M	USD	Annual
Contribution to investment - equity method	`PaymentsToEquityMethodInvestments`	$700.00K	USD	Annual
Cash recorded from consolidation of VIE	`ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity`	-	USD	Annual
Cash recorded from consolidation of VIE	`ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity`	$5.93M	USD	Annual
Cash recorded from consolidation of VIE	`ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity`	-	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-7.11M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$16.54M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-65.52M	USD	Annual
Dividends paid	`PaymentsOfDividendsCommonStock`	$31.09M	USD	Annual
Dividends paid	`PaymentsOfDividendsCommonStock`	$14.03M	USD	Annual
Dividends paid	`PaymentsOfDividendsCommonStock`	$62.07M	USD	Annual
Repayments on long-term debt	`RepaymentsOfOtherLongTermDebt`	$238.33M	USD	Annual
Repayments on long-term debt	`RepaymentsOfOtherLongTermDebt`	$204.68M	USD	Annual
Repayments on long-term debt	`RepaymentsOfOtherLongTermDebt`	$3.87M	USD	Annual
Borrowings on long-term debt	`ProceedsFromIssuanceOfOtherLongTermDebt`	$284.53M	USD	Annual
Borrowings on long-term debt	`ProceedsFromIssuanceOfOtherLongTermDebt`	$3.60M	USD	Annual
Borrowings on long-term debt	`ProceedsFromIssuanceOfOtherLongTermDebt`	$180.57M	USD	Annual
Payment of finance lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$675.00K	USD	Annual
Payment of finance lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$561.00K	USD	Annual
Payment of finance lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$208.00K	USD	Annual
Proceeds from exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$9.06M	USD	Annual
Proceeds from exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$1.52M	USD	Annual
Proceeds from exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$8.63M	USD	Annual
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	$9.25M	USD	Annual
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	$5.74M	USD	Annual
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	$10.19M	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$40.13M	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Purchase of non-controlling interest	`PaymentsOfDividendsMinorityInterest`	$1.47M	USD	Annual
Purchase of non-controlling interest	`PaymentsOfDividendsMinorityInterest`	$5.05M	USD	Annual
Purchase of non-controlling interest	`PaymentsOfDividendsMinorityInterest`	$78.00K	USD	Annual
Proceeds from sale of noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	Annual
Proceeds from sale of noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	$48.00K	USD	Annual
Proceeds from sale of noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	$436.00K	USD	Annual
Cost of debt issuances	`PaymentOfFinancingAndStockIssuanceCosts`	-	USD	Annual
Cost of debt issuances	`PaymentOfFinancingAndStockIssuanceCosts`	$727.00K	USD	Annual
Cost of debt issuances	`PaymentOfFinancingAndStockIssuanceCosts`	$3.93M	USD	Annual
Payment of contingent consideration liabilities	`PaymentForContingentConsiderationLiabilityFinancingActivities`	-	USD	Annual
Payment of contingent consideration liabilities	`PaymentForContingentConsiderationLiabilityFinancingActivities`	-	USD	Annual
Payment of contingent consideration liabilities	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$1.00M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-20.09M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.42M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-47.75M	USD	Annual
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$54.93M	USD	Annual
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$39.13M	USD	Annual
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$6.12M	USD	Annual
Cash, cash equivalents, and restricted cash, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$294.15M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$233.10M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$193.97M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$288.03M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$294.15M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$233.10M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$193.97M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$288.03M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$47.31M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	$56.57M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	$37.20M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$14.25M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$6.67M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$4.16M	USD	Annual
Right-of-use assets obtained in exchange for operating lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$25.12M	USD	Annual
Right-of-use assets obtained in exchange for operating lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	Annual
Right-of-use assets obtained in exchange for operating lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	Annual
Tax impact from APC dividends to APC Shareholders	`TemporaryEquityDividendsImpact`	$3.08M	USD	Annual
Tax impact from APC dividends to APC Shareholders	`TemporaryEquityDividendsImpact`	-	USD	Annual
Tax impact from APC dividends to APC Shareholders	`TemporaryEquityDividendsImpact`	-	USD	Annual
Distribution of real estate investments	`PaymentsForProceedsFromRealEstatePartnershipInvestmentNet`	-	USD	Annual
Distribution of real estate investments	`PaymentsForProceedsFromRealEstatePartnershipInvestmentNet`	-	USD	Annual
Distribution of real estate investments	`PaymentsForProceedsFromRealEstatePartnershipInvestmentNet`	$152.77M	USD	Annual
Dividend declared included in dividend payable	`DividendsPayableCurrentAndNoncurrent`	-	USD	Point-in-time
Dividend declared included in dividend payable	`DividendsPayableCurrentAndNoncurrent`	$71.00K	USD	Point-in-time
Dividend declared included in dividend payable	`DividendsPayableCurrentAndNoncurrent`	-	USD	Point-in-time
Issuance of financing obligation for business combinations	`IssuanceOfFinancingObligationForBusinessCombination`	-	USD	Annual
Issuance of financing obligation for business combinations	`IssuanceOfFinancingObligationForBusinessCombination`	-	USD	Annual
Issuance of financing obligation for business combinations	`IssuanceOfFinancingObligationForBusinessCombination`	$12.71M	USD	Annual
Cashless exercise of warrants	`CashlessExerciseOfStockOptions`	-	USD	Annual
Cashless exercise of warrants	`CashlessExerciseOfStockOptions`	-	USD	Annual
Cashless exercise of warrants	`CashlessExerciseOfStockOptions`	$694.00K	USD	Annual
Fixed asset obtained in exchange for finance lease liabilities	`FixedAssetObtainedInExchangeForFinanceLeaseLiabilities`	-	USD	Annual
Fixed asset obtained in exchange for finance lease liabilities	`FixedAssetObtainedInExchangeForFinanceLeaseLiabilities`	$971.00K	USD	Annual
Fixed asset obtained in exchange for finance lease liabilities	`FixedAssetObtainedInExchangeForFinanceLeaseLiabilities`	$486.00K	USD	Annual
Common stock issued in business combination	`StockIssued1`	-	USD	Annual
Common stock issued in business combination	`StockIssued1`	$800.00K	USD	Annual
Common stock issued in business combination	`StockIssued1`	$1.00M	USD	Annual
Mortgage loan	`MortgageLoanRelatedToPropertySales1`	$16.27M	USD	Annual
Mortgage loan	`MortgageLoanRelatedToPropertySales1`	-	USD	Annual
Mortgage loan	`MortgageLoanRelatedToPropertySales1`	-	USD	Annual
Cancellation of Restricted Stock Awards	`CancellationOfRestrictedStockAwards`	-	USD	Annual
Cancellation of Restricted Stock Awards	`CancellationOfRestrictedStockAwards`	-	USD	Annual
Cancellation of Restricted Stock Awards	`CancellationOfRestrictedStockAwards`	$334.00K	USD	Annual
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$288.03M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$233.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$293.81M	USD	Point-in-time
Restricted cash	`RestrictedCashEquivalentsNoncurrent`	$345.00K	USD	Point-in-time
Restricted cash	`RestrictedCashEquivalentsNoncurrent`	-	USD	Point-in-time
Restricted cash	`RestrictedCashEquivalentsNoncurrent`	-	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$294.15M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$233.10M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$193.97M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$288.03M	USD	Point-in-time

Stockholders Equity 53 line items

Line Item	Tag	Value	Unit	Period
Purchase of non-controlling interest	`MinorityInterestDecreaseFromRedemptions`	$4.34M	USD	Annual
Purchase of non-controlling interest	`MinorityInterestDecreaseFromRedemptions`	$78.00K	USD	Annual
Purchase of non-controlling interest	`MinorityInterestDecreaseFromRedemptions`	$75.00K	USD	Annual
Sale of non-controlling interest	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$66.00K	USD	Annual
Sale of non-controlling interest	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$106.00K	USD	Annual
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$9.25M	USD	Annual
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$5.74M	USD	Annual
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$10.04M	USD	Annual
Balance at beginning (in shares)	`SharesOutstanding`	46.58M	shares	Point-in-time
Balance at beginning (in shares)	`SharesOutstanding`	46.84M	shares	Point-in-time
Balance at beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$544.31M	USD	Point-in-time
Balance at beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$616.65M	USD	Point-in-time
Balance at beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$454.11M	USD	Point-in-time
Balance at beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$329.46M	USD	Point-in-time
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$48.94M	USD	Annual
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$71.69M	USD	Annual
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$65.28M	USD	Annual
Purchase of non-controlling interest	`MinorityInterestDecreaseFromRedemptions`	$4.34M	USD	Annual
Purchase of non-controlling interest	`MinorityInterestDecreaseFromRedemptions`	$78.00K	USD	Annual
Purchase of non-controlling interest	`MinorityInterestDecreaseFromRedemptions`	$75.00K	USD	Annual
Sale of non-controlling interest	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$66.00K	USD	Annual
Sale of non-controlling interest	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$106.00K	USD	Annual
Sale of shares by non-controlling interest	`StockIssuedDuringPeriodValueNoncontrollingInterest`	$40.13M	USD	Annual
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-933.00K	USD	Annual
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-321.00K	USD	Annual
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$9.06M	USD	Annual
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$8.63M	USD	Annual
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$1.52M	USD	Annual
Purchase of treasury shares (in shares)	`TreasuryStockSharesAcquired`	3.45M	shares	Annual
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$9.25M	USD	Annual
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$5.74M	USD	Annual
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$10.04M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$16.10M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$6.75M	USD	Annual
Issuance of shares for business acquisition	`StockIssuedDuringPeriodValueAcquisitions`	$1.00M	USD	Annual
Issuance of shares for business acquisition	`StockIssuedDuringPeriodValueAcquisitions`	$800.00K	USD	Annual
Investment in non-controlling interest	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$371.00K	USD	Annual
Investment in non-controlling interest	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$3.77M	USD	Annual
Acquisition of non-controlling interest	`NoncontrollingInterestIncreaseFromBusinessCombination`	$500.00K	USD	Annual
Cancellation of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$334.00K	USD	Annual
Cancellation of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$457.00K	USD	Annual
Non-controlling interest capital change	`NoncontrollingInterestIncreaseFromCapitalCharge`	$48.00K	USD	Annual
AAMG stock contingent consideration (see Note 21)	`AAMGEquityContingentConsideration`	$5.57M	USD	Annual
Dividends	`NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares`	$-3.90M	USD	Annual
Dividends	`NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares`	$23.89M	USD	Annual
Dividends	`NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares`	$-1.16M	USD	Annual
Transfer of common control entities	`StockholdersEquityTransferOfCommonControlEntities`	$2.45M	USD	Annual
Balance at ending (in shares)	`SharesOutstanding`	46.58M	shares	Point-in-time
Balance at ending (in shares)	`SharesOutstanding`	46.84M	shares	Point-in-time
Balance at ending	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$544.31M	USD	Point-in-time
Balance at ending	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$616.65M	USD	Point-in-time
Balance at ending	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$454.11M	USD	Point-in-time
Balance at ending	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$329.46M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.